拉萨地区冠心病与幽门螺杆菌感染相关性研究

目的探讨西藏拉萨地区幽门螺杆菌（Helicobacter pyloric，Hp）感染与冠心病及多种危险因素的关系。为该地区冠心病的防治提供依据。方法分为冠心病组46例和非冠心病组51例，应用检测血抗HpIgG及-C-尿素呼气试验方法检测Hp感染情况，并分别测定各组血脂、血糖、餐后2h血糖、C反应蛋白、纤维蛋白原、白细胞总数。结果冠心病组患者血清抗HpIgG阳性率为50．0％（23／46），明显高于非冠心病组的23．5％（12／51），P〈0．05；冠心病患者Hp现症感染率为54．3％（25／46），明显高于非冠心病组的31．3％（27／51），P〈0．05；冠心病组Hp感染患者血脂、空腹及餐后2h血糖、C反应蛋白、纤维蛋白原较非感染患者明显升高（P〈0．05）。结论Hp感染与冠心病相关，可能是拉萨地区冠心病发病的独立危险因素。     

Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy.

Complications in a donor are a distressing but inevitable occurrence, since graft procurement is a major undertaking. Although the technique for procurement has some similarities to hepatic resection, a donor is very unlike a patient with malignancy. The risk factors identified in these patients cannot be extrapolated to donors. Donor hepatectomy carried out from June 1995 to March 2005 in Chang Gung Memorial Hospital, Kaohsiung Medical Center was reviewed with the aim of identifying risk factors for complications. There were 204 living donor liver transplants, with 205 donor hepatectomies, as 1 living donor liver transplantation was a dual graft. Ten donors (4.88%) suffered complications. There was no difference in terms of age, gender, body weight, operation, and parenchymal time between those who had complications and those who did not. There was also no difference in liver function tests between the 2 groups of donors, but the total bilirubin was significantly higher in donors with complications. The graft weight and remnant liver volume were also similar. The proportion of donors with fatty liver was the same between the 2 groups. The mean blood loss in donors with complications was 170 +/- 79 mL, and that for donors without complications was 95 +/- 77 mL. There was a statistically significant greater blood loss in donors with complications (P < 0.05). The number of segments removed in donors with complications was also higher compared to donors without complications (P < 0.03). Using multivariate analysis, intraoperative blood loss and the number of segments removed were found to be independent risk factors for donor complications. Intraoperative blood loss during graft procurement must be kept low to minimize complications in donors.     

局部进展期胰腺癌调强放疗剂量递增临床研究

目的探索调强放射治疗 (IMRT)提高进展期胰腺癌局部肿瘤靶区剂量以及减少周围正常组织照射剂量的可能性。　方法 2 1例局部进展期胰腺癌患者接受同期放化疗。放射治疗分第一阶段予常规放射治疗 ,剂量30Gy/ 15次 / 3周 ;第二阶段强调放射治疗 ,肿瘤靶区分割剂量 3Gy/次 ,总剂量为 2 1～30Gy ,在 2周内分 7～10次完成。总剂量递增水平 :5 1、5 4、5 7、6 0Gy。在放射治疗过程中 ,每个治疗日 5 -FU静脉点滴。　结果 16例完成治疗计划 ,分别为 5 1Gy 3例、5 4Gy 3例、5 7Gy 3例 ,6 0Gy 7例。 13例治疗前CA19- 9值升高 ,中位值治疗前后分别为 716、2 5 5U/ml(P <0 .0 0 1)。 14例以疼痛为主的患者至少减少 1/ 3～1/ 2的麻醉药品用量 ,其中 5例疼痛症状完全消失。10例患者治疗后卡氏评分有提高。　结论局部进展期胰腺癌患者接受适形调强放疗并同期应用 5 -Fu化疗增敏 ,可获得确切的姑息治疗作用 ,肿瘤剂量 6 0Gy分 2 5次在 5周完成 ,无严重的放射治疗相关的急性毒性反应     

军人花粉症106例快速免疫治疗

目的　探讨军人花粉症治疗的有效方法。方法　采用提高起始浓度和快速递增浓度 ,上臂外侧皮下注射的方法对 10 6位军人花粉症患者行快速免疫治疗 ,并对每一位患者治疗前后检测血清中总IgE和嗜酸细胞阳离子蛋白 (ECP)。 结果　治疗前后患者总IgE和ECP值有显著性差异。 10 6例患者经 1～ 3年随访复查 ,78例 2个以上发病季节未发作 ,或仅有轻微鼻痒、眼痒 ,18例症状减轻 ,发病时间缩短半月 ,10例症状无明显改善。显效 82例 ,有效 14例 ,无效 10例 ,总有效率为 90 .5 7%。结论　快速免疫治疗能使患者血清总IgE和ECP下降 ,对军人花粉症疗效好。     

Mice aorta loop grafting： A new model which separate vascular rejection and neointimal formation in chronic rejection

To study the cause and mechanism of transplantation vasculopathy which characterized by accelerated graft arteriosclerosis ( AGA), we estabfished a mouse aorta graft model. Methods: A segment of thoracic aortas of B10. A (2R) mice were transplanted to C57BL/10 mice abdominal aorta by end to side anastomoses. The different time point collected grafts were analyzed by morphological, histochemical and electro microscopic methods. Results:Rejection was manifested as a concentric progressive destruction of the smooth muscle cells. In contrast, the endothelial inflammation and subsequent ncointimal proliferation characteristic of AGA was localized to the regions of turbulent flow, i.e. the junction of the graft with the recipient aorta. Conclusion: This model separates the processes of rejec-tion and neointimal formation which usually manifested together in the lesion of AGA, elucidate that different mecha-nisms control vascular rejection and neointimal formation in chronic rejection.     

颅内动脉瘤破裂出血患者血清PRL、GH的动态变化

目的　测定颅内动脉瘤破裂出血患者血清泌乳素 (PRL)、生长激素 (GH)的含量变化 ,探讨其与病情演变的关系。方法　对 3 5例颅内动脉瘤破裂出血患者发病后 1～ 3d ,发病后 7～ 9d ,发病后 13～ 15d血清PRL、GH进行动态观察 ,用TCD检测大脑中动脉血流速度 (VMCA)。结果　颅内动脉瘤破裂出血患者血清PRL、GH发病后 1～ 3d、发病后 7～ 9d各均值明显高于对照组 (P <0 .0 5 ) ,尤以发病后 7～ 9d变化最明显 ;术前、术后有脑血管痉挛组和非脑血管痉挛组也有明显差异 (P <0 .0 5 )。结论　血清GH、PRL含量与蛛网膜下腔出血 (SAH)的病情演变、脑血管痉挛 (CVS)有关     

中长链脂肪酸食用油可降低超重高甘油三酯血症患者体脂肪和血脂水平

T可以减少超重高甘油三酯血症患者体脂肪,降低血甘油三酯和低密度脂蛋白胆固醇水平.     

先天性风吹手畸形的治疗

目的探讨先天性风吹手畸形(windblown hand)的治疗。方法对18例患者采用分次手术的方法:一期改善拇指功能;二期纠正手指尺偏畸形;三期解决手掌、手指屈曲。结果术后随访6～72个月,3例患者失访。15例中有11例拇指外展、对掌、对指功能恢复,效果满意;9例手指尺偏畸形得到纠正,5例再次手术,经系统康复训练后4例畸形纠正,1例部分纠正。结论先天性风吹手畸形的治疗应分次手术,每次解决1个主要问题,配合系统的康复才能获得满意的效果。     

喉返神经解剖在甲状腺手术中的应用研究

目的探讨解剖喉返神经在甲状腺手术中的应用。方法回顾分析因甲状腺疾病行手术治疗的236例患者的临床资料,共施行甲状腺手术335侧次;甲组101例行甲状腺手术158侧次,术中均未解剖喉返神经,其中57例行双侧甲状腺手术。乙组135例行甲状腺手术同时解剖喉返神经177侧次,其中42例因双侧甲状腺手术而行双侧喉返神经解剖。结果喉返神经损伤均发生在切除甲状腺范围包含背侧腺体时。甲组暂时性损伤2例,永久性损伤1例,损伤率为1.9%;乙组暂时性损伤1例,无永久性损伤病例,损伤率为0.56%;两组差异有统计学意义(χ2=0.382,P<0.01)。结论甲状腺手术中解剖喉返神经能减少喉返神经的损伤,切除背侧腺体时应常规解剖喉返神经。